Search results
UPDATE 3-Geron's blood disorder drug gets FDA advisers' backing
Reuters via Yahoo Finance UK· 4 months agoAdvisers to the U.S. Food and Drug Administration on Thursday backed benefits of Geron's blood disorder drug, saying it outweighed the risks associated with the treatment, based on data from ...
Engine Capital pushes for changes at cancer therapy developer 2seventy bio
Reuters via Yahoo Finance UK· 7 months agoEngine Capital, which owns about a 3% stake in 2seventy bio, said the company should exclusively focus on its blood cancer therapy Abecma, and explore ways to "immediately cease or monetize ...
CORRECTED-Engine Capital urges 2seventy bio to appoint former finance chief Baird as CEO
Reuters via Yahoo Finance UK· 7 months ago(Corrects paragraph 1 and headline to clarify that Baird is former finance chief, not current) Dec 6 (Reuters) - Activist investor Engine Capital on Wednesday urged 2seventy bio to appoint its ...
Tesla shares gain as Baird Equity adds stock to 'best ideas' list
Reuters via Yahoo Finance UK· 11 months agoTesla's shares have risen about 85% so far this year on the back of growing sales despite a margin...
Sarepta slides as FDA about-turn on panel clouds gene therapy approval path
Reuters via Yahoo Finance UK· 1 year ago(Reuters) -Shares of Sarepta Therapeutics Inc slumped as much as 21% on Friday on uncertainty over...
Raytheon sees castings shortages spilling into next year amid aftermarket demand
Reuters via Yahoo Finance UK· 2 years agoU.S. aerospace giant Raytheon Technologies Corp said on Tuesday stability in supply of castings,...